Cargando…
Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update
BACKGROUND: In Canada, more than 2 million people live with osteoporosis, a disease that increases the risk for fractures, which result in excess mortality and morbidity, decreased quality of life and loss of autonomy. This guideline update is intended to assist Canadian health care professionals in...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610956/ https://www.ncbi.nlm.nih.gov/pubmed/37816527 http://dx.doi.org/10.1503/cmaj.221647 |
_version_ | 1785128378697777152 |
---|---|
author | Morin, Suzanne N. Feldman, Sidney Funnell, Larry Giangregorio, Lora Kim, Sandra McDonald-Blumer, Heather Santesso, Nancy Ridout, Rowena Ward, Wendy Ashe, Maureen C. Bardai, Zahra Bartley, Joan Binkley, Neil Burrell, Steven Butt, Debra Cadarette, Suzanne M. Cheung, Angela M. Chilibeck, Phil Dunn, Sheila Falk, Jamie Frame, Heather Gittings, William Hayes, Kaleen Holmes, Carol Ioannidis, George Jaglal, Susan B. Josse, Robert Khan, Aliya A. McIntyre, Virginia Nash, Lynn Negm, Ahmed Papaioannou, Alexandra Ponzano, Matteo Rodrigues, Isabel B. Thabane, Lehana Thomas, Christine A. Tile, Lianne Wark, John D. |
author_facet | Morin, Suzanne N. Feldman, Sidney Funnell, Larry Giangregorio, Lora Kim, Sandra McDonald-Blumer, Heather Santesso, Nancy Ridout, Rowena Ward, Wendy Ashe, Maureen C. Bardai, Zahra Bartley, Joan Binkley, Neil Burrell, Steven Butt, Debra Cadarette, Suzanne M. Cheung, Angela M. Chilibeck, Phil Dunn, Sheila Falk, Jamie Frame, Heather Gittings, William Hayes, Kaleen Holmes, Carol Ioannidis, George Jaglal, Susan B. Josse, Robert Khan, Aliya A. McIntyre, Virginia Nash, Lynn Negm, Ahmed Papaioannou, Alexandra Ponzano, Matteo Rodrigues, Isabel B. Thabane, Lehana Thomas, Christine A. Tile, Lianne Wark, John D. |
author_sort | Morin, Suzanne N. |
collection | PubMed |
description | BACKGROUND: In Canada, more than 2 million people live with osteoporosis, a disease that increases the risk for fractures, which result in excess mortality and morbidity, decreased quality of life and loss of autonomy. This guideline update is intended to assist Canadian health care professionals in the delivery of care to optimize skeletal health and prevent fractures in postmenopausal females and in males aged 50 years and older. METHODS: This guideline is an update of the 2010 Osteoporosis Canada clinical practice guideline on the diagnosis and management of osteoporosis in Canada. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework and quality assurance as per Appraisal of Guidelines for Research and Evaluation (AGREE II) quality and reporting standards. Primary care physicians and patient partners were represented at all levels of the guideline committees and groups, and participated throughout the entire process to ensure relevance to target users. The process for managing competing interests was developed before and continued throughout the guideline development, informed by the Guideline International Network principles. We considered benefits and harms, patient values and preferences, resources, equity, acceptability and feasibility when developing recommendations; the strength of each recommendation was assigned according to the GRADE framework. RECOMMENDATIONS: The 25 recommendations and 10 good practice statements are grouped under the sections of exercise, nutrition, fracture risk assessment and treatment initiation, pharmacologic interventions, duration and sequence of therapy, and monitoring. The management of osteoporosis should be guided by the patient’s risk of fracture, based on clinical assessment and using a validated fracture risk assessment tool. Exercise, nutrition and pharmacotherapy are key elements of the management strategy for fracture prevention and should be individualized. INTERPRETATION: The aim of this guideline is to empower health care professionals and patients to have meaningful discussions on the importance of skeletal health and fracture risk throughout older adulthood. Identification and appropriate management of skeletal fragility can reduce fractures, and preserve mobility, autonomy and quality of life. |
format | Online Article Text |
id | pubmed-10610956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106109562023-10-28 Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update Morin, Suzanne N. Feldman, Sidney Funnell, Larry Giangregorio, Lora Kim, Sandra McDonald-Blumer, Heather Santesso, Nancy Ridout, Rowena Ward, Wendy Ashe, Maureen C. Bardai, Zahra Bartley, Joan Binkley, Neil Burrell, Steven Butt, Debra Cadarette, Suzanne M. Cheung, Angela M. Chilibeck, Phil Dunn, Sheila Falk, Jamie Frame, Heather Gittings, William Hayes, Kaleen Holmes, Carol Ioannidis, George Jaglal, Susan B. Josse, Robert Khan, Aliya A. McIntyre, Virginia Nash, Lynn Negm, Ahmed Papaioannou, Alexandra Ponzano, Matteo Rodrigues, Isabel B. Thabane, Lehana Thomas, Christine A. Tile, Lianne Wark, John D. CMAJ Guideline BACKGROUND: In Canada, more than 2 million people live with osteoporosis, a disease that increases the risk for fractures, which result in excess mortality and morbidity, decreased quality of life and loss of autonomy. This guideline update is intended to assist Canadian health care professionals in the delivery of care to optimize skeletal health and prevent fractures in postmenopausal females and in males aged 50 years and older. METHODS: This guideline is an update of the 2010 Osteoporosis Canada clinical practice guideline on the diagnosis and management of osteoporosis in Canada. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework and quality assurance as per Appraisal of Guidelines for Research and Evaluation (AGREE II) quality and reporting standards. Primary care physicians and patient partners were represented at all levels of the guideline committees and groups, and participated throughout the entire process to ensure relevance to target users. The process for managing competing interests was developed before and continued throughout the guideline development, informed by the Guideline International Network principles. We considered benefits and harms, patient values and preferences, resources, equity, acceptability and feasibility when developing recommendations; the strength of each recommendation was assigned according to the GRADE framework. RECOMMENDATIONS: The 25 recommendations and 10 good practice statements are grouped under the sections of exercise, nutrition, fracture risk assessment and treatment initiation, pharmacologic interventions, duration and sequence of therapy, and monitoring. The management of osteoporosis should be guided by the patient’s risk of fracture, based on clinical assessment and using a validated fracture risk assessment tool. Exercise, nutrition and pharmacotherapy are key elements of the management strategy for fracture prevention and should be individualized. INTERPRETATION: The aim of this guideline is to empower health care professionals and patients to have meaningful discussions on the importance of skeletal health and fracture risk throughout older adulthood. Identification and appropriate management of skeletal fragility can reduce fractures, and preserve mobility, autonomy and quality of life. CMA Impact Inc. 2023-10-10 2023-10-10 /pmc/articles/PMC10610956/ /pubmed/37816527 http://dx.doi.org/10.1503/cmaj.221647 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Guideline Morin, Suzanne N. Feldman, Sidney Funnell, Larry Giangregorio, Lora Kim, Sandra McDonald-Blumer, Heather Santesso, Nancy Ridout, Rowena Ward, Wendy Ashe, Maureen C. Bardai, Zahra Bartley, Joan Binkley, Neil Burrell, Steven Butt, Debra Cadarette, Suzanne M. Cheung, Angela M. Chilibeck, Phil Dunn, Sheila Falk, Jamie Frame, Heather Gittings, William Hayes, Kaleen Holmes, Carol Ioannidis, George Jaglal, Susan B. Josse, Robert Khan, Aliya A. McIntyre, Virginia Nash, Lynn Negm, Ahmed Papaioannou, Alexandra Ponzano, Matteo Rodrigues, Isabel B. Thabane, Lehana Thomas, Christine A. Tile, Lianne Wark, John D. Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title | Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title_full | Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title_fullStr | Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title_full_unstemmed | Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title_short | Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update |
title_sort | clinical practice guideline for management of osteoporosis and fracture prevention in canada: 2023 update |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610956/ https://www.ncbi.nlm.nih.gov/pubmed/37816527 http://dx.doi.org/10.1503/cmaj.221647 |
work_keys_str_mv | AT morinsuzannen clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT feldmansidney clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT funnelllarry clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT giangregoriolora clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT kimsandra clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT mcdonaldblumerheather clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT santessonancy clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT ridoutrowena clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT wardwendy clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT ashemaureenc clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT bardaizahra clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT bartleyjoan clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT binkleyneil clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT burrellsteven clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT buttdebra clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT cadarettesuzannem clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT cheungangelam clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT chilibeckphil clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT dunnsheila clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT falkjamie clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT frameheather clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT gittingswilliam clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT hayeskaleen clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT holmescarol clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT ioannidisgeorge clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT jaglalsusanb clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT josserobert clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT khanaliyaa clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT mcintyrevirginia clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT nashlynn clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT negmahmed clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT papaioannoualexandra clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT ponzanomatteo clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT rodriguesisabelb clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT thabanelehana clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT thomaschristinea clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT tilelianne clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update AT warkjohnd clinicalpracticeguidelineformanagementofosteoporosisandfracturepreventionincanada2023update |